As an important biomarker, HNA-2 (CD177) is over-expressed in neutrophils from patients with myeloproliferative disorders including polycythemia vera, essential thromobocythemia, idiopathic myelofibrocythemia, and hypereosinophilic syndrome [6,14]. The gene discussed is CD177; the disease is acquired polycythemia vera.